Chagas disease is an independent predictor of stroke and death in a cohort of heart failure patients

被引:12
作者
Cerqueira-Silva, Thiago [1 ,2 ]
Goncalves, Beatriz M. M. [2 ]
Pereira, Camila B. [2 ]
Porto, Louise M. [2 ]
Marques, Maria E. L. [2 ]
Santos, Leila S. B. [2 ]
Oliveira, Murilo A. [2 ]
Felix, Iuri F. [2 ]
de Sousa, Paulo R. S. P. [2 ]
Muinos, Pedro J. R. [2 ]
Maia, Renata M. [2 ]
Catto, Marilia B. [2 ]
Andrade, Alisson L. [2 ]
Jesus, Pedro A. P. [2 ]
Aras, Roque [2 ]
Oliveira-Filho, Jamary [1 ,2 ]
机构
[1] Univ Fed Bahia, Postgrad Program Hlth Sci, Salvador, BA, Brazil
[2] Univ Fed Bahia, Stroke & Cardiomyopathy Clin, Salvador, BA, Brazil
关键词
Stroke; Chagas disease; heart failure; risk factors; epidemiology; ischemic stroke; VENTRICULAR SYSTOLIC DYSFUNCTION; ISCHEMIC-STROKE; EJECTION FRACTION; RISK-FACTORS; ASPIRIN USE; MORTALITY;
D O I
10.1177/17474930211006284
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Aims: Chagas disease is a common cause of heart failure (HF) and death in developing countries. Although stroke is known to occur in these patients, an accurate estimate of stroke incidence is lacking. We aimed to determine the incidence of stroke and death in patients with HF, comparing Chagas and non-Chagas etiologies. Methods: Cohort of stroke-free patients with HF (Framingham criteria) followed in a university-based outpatient clinic in Brazil. Baseline characteristics included sociodemographic, risk factor assessment, echocardiographic and electrocardiographic findings. Chagas disease was defined by appropriate serologic tests. Cause-specific Cox regression was used to search for predictors of stroke or death as separate outcomes. Results: We studied 565 patients with HF between January 2003 and December 2018, mean age 54.3 +/- 12.9 years, 305 (54.0%) females, 271/535 (50.7%) with Chagas disease. Chagas patients were older (55.5 vs. 53.1 years), more frequently women (60.5% vs. 47.3%), less frequently harbored coronary artery disease (14.5% vs. 34.1%) when compared to non-Chagas patients. Echocardiography showed more severe disease among non-Chagas patients [median left ventricle ejection fraction (LVEF) 37.3% vs. 47.0%]. Over a mean 42.9 (+/- 34.4) months, we followed 404 (71.5%) patients, completing 1442 patient-years of follow-up. Stroke incidence was higher in Chagas when compared to non-Chagas patients (20.2 vs. 13.9 events per 1000 patient-years), while death rate was similar (41.6 vs. 43.1 deaths per 1000 patient-years). In the multivariable analysis for stroke outcome adjusted for LVEF and arrhythmias, cause-specific hazard ratio (CSHR) for Chagas was 2.54 (95% confidence interval 1.01-6.42, p = 0.048). Chagas disease was also associated with increased risk of death (CSHR 1.83; 95% confidence interval 1.04-3.24, p = 0.037). Conclusion: Chagas disease is associated with increased risk of stroke and death when compared to other etiologies of HF, independently of HF severity or cardiac arrhythmias, suggesting other factors contribute to increased stroke risk and mortality in Chagas disease. Early prevention and treatment of Chagas disease is imperative to reduce a later risk of stroke in endemic areas.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 32 条
  • [1] A computerized algorithm for etiologic classification of ischemic stroke - The causative classification of stroke system
    Ay, Hakan
    Benner, Thomas
    Arsava, E. Murat
    Furie, Karen L.
    Singhal, Aneesh B.
    Jensen, Matt B.
    Ayata, Cenk
    Towfighi, Amytis
    Smith, Eric E.
    Chong, Ji Y.
    Koroshetz, Walter J.
    Sorensen, A. Gregory
    [J]. STROKE, 2007, 38 (11) : 2979 - 2984
  • [2] The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
    Berry, C.
    Doughty, R. N.
    Granger, C.
    Kober, L.
    Massie, B.
    McAlister, F.
    McMurray, J.
    Pocock, S.
    Poppe, K.
    Swedberg, K.
    Somaratne, J.
    Whalley, G. A.
    Ahmed, A.
    Andersson, B.
    Bayes-Genis, A.
    Berry, C.
    Cowie, M.
    Cubbon, R.
    Doughty, R. N.
    Ezekowitz, J.
    Gonzalez-Juanatey, J.
    Gorini, M.
    Gotsman, I.
    Grigorian-Shamagian, L.
    Guazzi, M.
    Kearney, M.
    Kober, L.
    Komajda, M.
    di Lenarda, A.
    Lenzen, M.
    Lucci, D.
    Macin, S.
    Madsen, B.
    Maggioni, A.
    Martinez-Selles, M.
    McAlister, F.
    Oliva, F.
    Poppe, K.
    Rich, M.
    Richards, M.
    Senni, M.
    Squire, I.
    Taffet, G.
    Tarantini, L.
    Tribouilloy, C.
    Troughton, R.
    Tsutsui, H.
    Whalley, G. A.
    Doughty, R. N.
    Earle, N.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (14) : 1750 - 1757
  • [3] Clinical course of Chagas' heart disease: A comparison with dilated cardiomyopathy
    Bestetti, RB
    Muccillo, G
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1997, 60 (02) : 187 - 193
  • [4] Stroke Risk Factors, Genetics, and Prevention
    Boehme, Amelia K.
    Esenwa, Charles
    Elkind, Mitchell S. V.
    [J]. CIRCULATION RESEARCH, 2017, 120 (03) : 472 - 495
  • [5] Increased mortality attributed to Chagas disease: a systematic review and meta-analysis
    Cucunuba, Zulma M.
    Okuwoga, Omolade
    Basanez, Maria-Gloria
    Nouvellet, Pierre
    [J]. PARASITES & VECTORS, 2016, 9
  • [6] Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: Evidence for gender differences in the studies of left ventricular dysfunction trials
    Dries, DL
    Rosenberg, YD
    Waclawiw, MA
    Domanski, MJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (05) : 1074 - 1080
  • [7] Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease -: A prospective study in middle-aged to elderly men with treated hypertension
    Fagerberg, B
    Gnarpe, J
    Gnarpe, H
    Agewall, S
    Wikstrand, J
    [J]. STROKE, 1999, 30 (02) : 299 - 305
  • [8] Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
    Felker, GM
    Thompson, RE
    Hare, JM
    Hruban, RH
    Clemetson, DE
    Howard, DL
    Baughman, KL
    Kasper, EK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (15) : 1077 - 1084
  • [9] The long-term outcome of patients with hypertensive cardiomyopathy
    Frimm, CD
    Soufen, HN
    Koike, MK
    Pereira, VFA
    Cúri, M
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (05) : 393 - 400
  • [10] Potential new risk factors for ischemic stroke - What is their potential?
    Hankey, Graeme J.
    [J]. STROKE, 2006, 37 (08) : 2181 - 2188